Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

Serologic Studies In Patients With Systemic Lupus Erythematosus And Central Nervous System Dysfunction

Serologic Studies In Patients With Systemic Lupus Erythematosus And Central Nervous System... Serologic studies were performed on 25 patients with systemic lupus erythematosus (SLE) during 29 acute episodes of central nervous system (CNS) disease. Increased anti‐DNA antibody and decreased total serum hemolytic complement activity were observed only in those patients with associated extra‐CNS disease manifestations. Patients with isolated CNS disease were otherwise in apparent clinical and serological remission regarding these two indices. No special association of cold‐reactive IgM antilymphocyte antibodies was demonstrable in patients with ongoing CNS injury. Of special interest was an increased incidence of anti‐Sm antibodies in the patients with CNS dysfunction relative to that in a large group of patients without neuropsychiatric disease. The incidence of anti‐RNP was not increased. The data do not support direct involvement in SLE brain injury of either DNA/anti‐DNA complexes or of lymphocytotoxic antibodies cross‐reactive with brain cells, but do suggest an association of anti‐Sm with CNS disease in this disorder. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Arthritis & Rheumatism Wiley

Serologic Studies In Patients With Systemic Lupus Erythematosus And Central Nervous System Dysfunction

Loading next page...
 
/lp/wiley/serologic-studies-in-patients-with-systemic-lupus-erythematosus-and-0sVkO7BRDV

References (35)

Publisher
Wiley
Copyright
Copyright © 1978 American College of Rheumatology
ISSN
0004-3591
eISSN
1529-0131
DOI
10.1002/art.1780210301
Publisher site
See Article on Publisher Site

Abstract

Serologic studies were performed on 25 patients with systemic lupus erythematosus (SLE) during 29 acute episodes of central nervous system (CNS) disease. Increased anti‐DNA antibody and decreased total serum hemolytic complement activity were observed only in those patients with associated extra‐CNS disease manifestations. Patients with isolated CNS disease were otherwise in apparent clinical and serological remission regarding these two indices. No special association of cold‐reactive IgM antilymphocyte antibodies was demonstrable in patients with ongoing CNS injury. Of special interest was an increased incidence of anti‐Sm antibodies in the patients with CNS dysfunction relative to that in a large group of patients without neuropsychiatric disease. The incidence of anti‐RNP was not increased. The data do not support direct involvement in SLE brain injury of either DNA/anti‐DNA complexes or of lymphocytotoxic antibodies cross‐reactive with brain cells, but do suggest an association of anti‐Sm with CNS disease in this disorder.

Journal

Arthritis & RheumatismWiley

Published: Apr 1, 1978

There are no references for this article.